After Plunging 33.8% in 4 Weeks, Here's Why the Trend Might Reverse for Twist Bioscience (TWST)

Core Viewpoint - Twist Bioscience (TWST) has experienced significant selling pressure, resulting in a 33.8% decline in stock price over the past four weeks, but analysts anticipate improved earnings in the near future [1] Group 1: Technical Analysis - The Relative Strength Index (RSI) is a key technical indicator used to identify oversold conditions, with a reading below 30 typically indicating that a stock is oversold [2] - TWST's current RSI reading is 23.07, suggesting that the heavy selling may be exhausting, indicating a potential for a price rebound [5] - RSI helps investors identify potential entry points for stocks that have fallen below their fair value due to excessive selling pressure [3] Group 2: Fundamental Analysis - There has been a consensus among sell-side analysts to raise earnings estimates for TWST, with a 4.3% increase in the consensus EPS estimate over the last 30 days [7] - An upward trend in earnings estimate revisions is generally associated with price appreciation in the near term [7] - TWST holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate trends and EPS surprises, indicating strong potential for a turnaround [8]